Eli Lilly files six lawsuits targeting black-market retatrutide sellers in US - LLY News | RalliesEli Lilly files six lawsuits targeting black-market retatrutide sellers in US
L
LLY• Lilly expands legal campaign against illegal retatrutide sales
- Eli Lilly escalated its legal campaign against black-market retatrutide, filing six new lawsuits against U.S. sellers.
- Targets include compounding pharmacies, medical spas, and online sellers accused of marketing unapproved retatrutide for human use.
- Retatrutide remains investigational in Phase 3 trials; no regulator has cleared any retatrutide medicine for human use.
- Lilly also urged platforms, payment firms, shippers, and regulators to cut off infrastructure used to sell the drug illegally.
- The company reported more than 14,000 unlawful online listings and referred more than 200 individuals and entities to U.S. authorities.
NBIX
•
